<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01042860</url>
  </required_header>
  <id_info>
    <org_study_id>061052</org_study_id>
    <nct_id>NCT01042860</nct_id>
  </id_info>
  <brief_title>The Influence of Lutein Supplements on Age-related Macular Degeneration</brief_title>
  <official_title>The Influence of Lutein Supplements on Age-related Macular Degeneration</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cognis Deutschland GmbH &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <brief_summary>
    <textblock>
      Rationale: Age-related macular degeneration is the most common cause of blindness in the
      industrialized world. Macular pigment is hypothesized to protect against the vision loss in
      this disease.

      Objective: 1. To study if the macular pigment optical density can be raised by lutein
      supplementation. 2. To study if lutein supplementation can stop or slow down the decrease in
      visual functions.

      Study design: Randomized, double blind, placebo controlled intervention study.

      Study population: Eighty patients with early signs of age-related macular degeneration
      Intervention: The intervention group (40 subjects) receives 10 mg lutein per day, while the
      control group (40 subjects) gets a placebo.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2007</start_date>
  <completion_date type="Actual">August 2009</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Macular Pigment Optical Density</measure>
    <time_frame>Baseline, 4 months, 8 months, 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Acuity</measure>
    <time_frame>Baseline, 4 months, 8 months, 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Age-Related Macular Degeneration</condition>
  <arm_group>
    <arm_group_label>supplement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>lutein supplement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lutein</intervention_name>
    <description>Lutein supplement, 10 mg daily</description>
    <arm_group_label>supplement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  AMD grade 2 or 3

          -  visual acuity &gt; 0.5

          -  BMI &lt; 30

        Exclusion Criteria:

          -  using lutein supplements

          -  smoking

          -  diabetes

          -  diseases that interfere with lipid absorption

          -  other eye diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tos TJM Berendschot, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Eye Clinic Maastricht</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ian J Murray, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Manchester</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Eye Clinic Maastricht</name>
      <address>
        <city>Maastricht</city>
        <zip>6202 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Faculty of Life Sciences, University of Manchester</name>
      <address>
        <city>Manchester</city>
        <zip>M60 1QD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>January 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 5, 2010</study_first_submitted>
  <study_first_submitted_qc>January 5, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 6, 2010</study_first_posted>
  <last_update_submitted>January 7, 2010</last_update_submitted>
  <last_update_submitted_qc>January 7, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 8, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dr. Christine GÃ¤rtner</name_title>
    <organization>Cognis Deutschland GmbH &amp; Co. KG</organization>
  </responsible_party>
  <keyword>macular pigment</keyword>
  <keyword>lutein</keyword>
  <keyword>age-related macular degeneration</keyword>
  <keyword>AMD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Degeneration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

